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Abstract
Background: White matter (WM) and grey matter (GM) brain damage in multiple sclerosis (MS) is widespread, but the
extent of cerebellar involvement and impact on disability needs to be clarified.
Objective: This study aimed to assess cerebellar WM and GM atrophy and the degree of fibre coherence in the main
cerebellar connections, and their contribution to disability in relapsing–remitting MS (RRMS) and primary progressive
MS (PPMS).
Methods: Fourteen patients with RRMS, 12 patients with PPMS and 16 healthy controls were recruited. Cerebellar WM
and GM volumes and tractography-derived measures from the middle and superior cerebellar peduncles, including
fractional anisotropy (FA), mean diffusivity (MD), and directional diffusivities, were quantified from magnetic resonance
imaging (MRI). Patients were assessed on clinical scores, including the MS Functional Composite score subtests. Linear
regression models were used to compare imaging measures between 12 RRMS, 11 PPMS and 16 controls, and investigate
their association with clinical scores.
Results: Patients with PPMS showed reduced FA and increased radial diffusivity in the middle cerebellar peduncle
compared with controls and patients with RRMS. In PPMS, lower cerebellar WM volume was associated with worse
performance on the upper limb test. In the same patient group, we found significant relationships between superior
cerebellar peduncle FA and upper limb function, and between superior cerebellar peduncle FA, MD and radial diffusivity
and speed of walking.
Conclusion: These findings indicate reduced fibre coherence in the main cerebellar connections, and link damage in the
whole cerebellar WM, and, in particular, in the superior cerebellar peduncle, to motor deficit in PPMS.
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Introduction
Multiple sclerosis (MS) is a disabling neurological dis-
ease, characterized by inﬂammatory demyelinating
lesions within the white matter (WM) of the brain
and spinal cord, but also involving demyelination and
neuroaxonal loss within the grey matter (GM) and
‘normal-appearing’ WM.
1–4 Magnetic resonance imag-
ing (MRI) has enabled investigation into the extent of
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msj.sagepub.comdiﬀuse pathological damage in patients with MS using
a number of techniques including high-resolution
structural sequences, from which WM and GM vol-
umes can be calculated, and diﬀusion tensor imaging
(DTI), from which parameters sensitive to the integrity
of WM ﬁbres are derived, such as fractional anisotropy
(FA). Reduced volume (or atrophy) in patients com-
pared with controls is thought to reﬂect neuroaxonal
loss,
4,5 whilst reduced FA is thought to represent
axonal loss and demyelination.
6,7 FA information can
be measured along speciﬁc WM tracts by means of
diﬀusion-based tractography, which uses the informa-
tion contained in the DTI to track entire pathways
in vivo.
8
The cerebellum plays a major role in motor function,
and tissue damage within the cerebellum is thought to
contribute to disability in patients with MS. Cerebellar
atrophy is more extensive in patients with secondary
progressive MS and those with longer disease duration
when compared with people who have relapsing–remit-
ting (RR) MS and/or shorter disease duration, and cer-
ebellar atrophy has been shown to correlate with
clinical measures of disability.
9,10 The extent of involve-
ment of the cerebellar cortex speciﬁcally has been of
particular interest in recent years. Post-mortem studies
on MS tissue samples have shown demyelination in the
cerebellar cortex,
11,12 whilst signiﬁcant atrophy of the
cerebellar cortex measured from MRI in patients with
both relapsing and progressive MS has been
reported.
13,14 However, whether there is clinically rele-
vant atrophy in the cerebellar cortex of patients with
primary progressive (PP) MS needs further
investigation.
With respect to cerebellar WM, post-mortem studies
have shown demyelination in patients with MS,
11,12 but
to a lesser extent than the demyelination observed in
cerebellar GM. Whilst previous MRI studies have
found reductions in the volume of cerebellar WM in
MS patients compared with controls,
13,15 there is no
information about the extent of WM atrophy in
PPMS. Extensive WM changes, characterized by
reduced FA, have been observed across the brains of
patients with PPMS and RRMS using tract-based spa-
tial statistics, which compares groups on a voxel-wise
basis.
16,17 However, whether WM damage can be
detected in the main cerebellar connections in vivo in
patients with MS has not been investigated.
From a pathophysiological perspective, it is impor-
tant to determine whether there is an association
between pathological damage in the WM and that in
the GM, or whether the two are aﬀected independently.
Some studies have previously shown an association
between pathological processes occurring in the WM
and GM in some regions of the cerebral hemispheres
in patients with PPMS.
16,18 However, no correlation
between demyelination in the cerebellar cortex and
that in the WM was found in a post-mortem study,
12
suggesting that the mechanisms of damage in the WM
and GM may change across the brain regions or across
MS subtypes.
Thus, the aims of this study were to use MRI to
assess the diﬀerences in WM and GM volumes and
tractography-derived measures in the main cerebellar
connections between patients with RRMS and PPMS
and healthy controls, and to investigate the relative
contribution of cerebellar WM and GM injury in deter-
mining disability in both groups of patients. The asso-
ciations between WM and GM damage in both groups
of patients are also explored. The middle and superior
cerebellar peduncles were chosen for tractography
reconstruction and DTI-indices measurement because:
(i) the middle cerebellar peduncle (MCP) is the largest
aﬀerent system of the cerebellum with ﬁbres ending in
the cerebellar cortex (i.e. cortico-ponto-cerebellar path-
way); (ii) the superior cerebellar peduncle (SCP) con-
tains aﬀerent tracts to the cerebellum and eﬀerent ﬁbres
from the cerebellar nuclei, which inﬂuence parts of the
brain stem and the thalamus; (iii) both peduncles are




Subjects and clinical assessment
In total, 26 patients with MS (14 RRMS, mean age
44.9 years (SD 11.9), seven males; 12 PPMS, mean
age 55.6 years (SD 9.8), six males) and 16 healthy con-
trol subjects (mean age 40.4 years (SD 13.2), seven
males) were included in the study and underwent the
same MRI protocol. Healthy controls were age-
matched to the RRMS patients, but not the PPMS
patients; therefore, age was included in each step of
the statistical analysis (see below). One patient with
PPMS felt unwell during the scanning and did not com-
plete the protocol; two patients with RRMS were later
excluded (see below), leaving a total of 23 patients
(Table 1). All patients were clinically assessed on the
day of MR scanning using the Expanded Disability
Status Scale (EDSS),
21 which included the cerebellar
functional systems score (C-FSS). Clinical assessment
also included the Timed 25-foot Walk Test (TWT)
22
and the Nine-Hole Peg Test (9-HPT).
23 The average
of two trials of the TWT, and the average of four
trials of the 9-HPT (averaged as reciprocals of the
mean times from two trials for each hand) were
calculated.
24
Ethical approval was granted by the Joint Medical
Ethics Committee of the National Hospital for
Neurology and Neurosurgery and the Institute of
1080 Multiple Sclerosis Journal 17(9)Neurology, London. All subjects gave informed, writ-
ten consent.
MR image acquisition and analysis
MR imaging was performed on a 1.5T Signa
Echospeed scanner (GE Medical Systems, Milwaukee,
WI, USA). All subjects had brain T1-weighted inver-
sion-recovery prepared fast spoiled-gradient recall
(FSPGR) imaging (TR 14.3ms, TE 5.1ms, TI 450ms,
ﬂip angle 20 , matrix size 256 128, ﬁeld of view
310 160mm
2, 160 contiguous coronal slices, voxel
resolution 1.2 1.2 1.2mm). DTI data were acquired
using a single-shot diﬀusion-weighted (DW) echo
planar imaging sequence (FOV 220 220mm, matrix
96 96 reconstructed to 128 128, in-plane resolution
2.3 2.3mm
2 reconstructed to 1.7 1.7mm
2, 60 con-
tiguous axial slices, 2.3mm slice thickness, cardiac
gating (TR 20RR (&20s)), diﬀusion gradients applied





T1-weighted volumetric MRI were segmented into
GM, WM and cerebrospinal ﬂuid (CSF) using SPM5
(Statistical Parametric Mapping, Wellcome Trust
Centre for Neuroimaging, Institute of Neurology,
http://www.ﬁl.ion.ucl.ac.uk/spm).
27 Binary GM and
WM masks were converted into regions-of-interest
which were overlaid on the original MRI, and the cer-
ebellar tissue, corrected for lesion mis-classiﬁcation,
was delineated on coronal slices as described previ-
ously.
13 In addition, total intracranial volume (TIV)
was calculated for each subject as the sum of the
GM, WM, CSF and lesion volumes obtained from
SPM processing.
The processing of the diﬀusion data and the tracto-
graphy analysis were performed using tools available
in the FSL Library (http://www.fmrib.ox.ac.uk/fsl).
The diﬀusion data were processed using FDT
(FMRIB’s Diﬀusion Toolbox) v2.0.
28 Following data
conversion, DW images were corrected for motion and
eddy current distortion. A diﬀusion tensor model was
ﬁtted on a voxel-by-voxel basis and local modelling of
the diﬀusion parameters was performed using Markov
chain Monte Carlo sampling to build up a probability
distribution function of the primary diﬀusion direction
at each voxel.
28 The probabilistic tractography algo-
rithm provided by FSL
28 was used to reconstruct the
MCP and SCP. The MCP represents the largest of the
three cerebellar peduncles, and contains aﬀerent axons
that originate from the pontine nuclei, contributing to
the cortico–ponto–cerebellar pathway. The MCP medi-
ates complex brain functions, as it allows a ﬂow of infor-
mation from the cerebral cortex to the cerebellum.
29 The
SCP contains not only aﬀerent ﬁbres to the cerebellum
(i.e. ventral spinocerebellar tract), but also eﬀerent
ﬁbres from the dentate nucleus to the brain stem and
thalamus (i.e. the dentatorubral and dentatothalamic
tracts), which ultimately act on the lower motor neu-
rons.
30 For the MCP, two seed masks were positioned
over the middle part of the left and right MCP on the
standard MNI-152 T1-weighted (2mm) brain image
(MNI coordinates for left MCP x¼53, y¼45, z¼18;
for right MCP x¼36, y¼45, z¼18), while for the SCP,
two seed masks were designed over the middle part of
the left and right SCP on the same template (MNI coor-
dinates for left SCP x¼48, y¼44, z¼23; for right SCP
x¼41, y¼44, z¼23) (Figure 1).
These seed masks were then transformed into the
individual space of DW images using FLIRT. The
transformation matrix was based on the inverse and
concatenated transformation matrices obtained from
linear registration of the non-DW image to the T1-
weighted FSPGR image and the linear registration of
the T1-weighted FSPGR image to the MNI-152 brain
image. This automated approach was taken to avoid
introducing bias that could have resulted from manu-
ally placing seed masks on each subject’s image inde-
pendently, and was thus 100% reproducible. The
correct location of seed masks in native space was con-
ﬁrmed by visual inspection in all cases. Probabilistic
tractography was used to reconstruct ﬁbres passing
through the seed masks. Exclusion masks were placed
Table 1. Subject characteristics of the patients who contributed to the final results
RRMS (n¼12) PPMS (n¼11)
Age, years (mean (SD)) 45.0 (12.9) 56.3 (10.0)
Gender 7 males, 5 females 5 males, 6 females
Disease duration, years (mean (SD)) 8.8 (7.8) 12.6 (7.6)
EDSS (median (range)) 4.5 (2.0–6.5) 5.0 (2.5–7.5)
Cerebellar-FSS (median (range)) 0 (0–2) 2 (0–4)
25-foot timed walk, s (mean/median (range)) 8.3 / 8.4 (4.9–12.0) 26.2 / 7.9 (4.8–180)
Nine-hole peg test, s (mean/median (range)) 36.5 / 22.7 (19.6–158.6) 38.3 / 23.2 (18.9–162.7)
Cerebellar-FSS¼Cerebellar Functional System Score.
Anderson et al. 1081in the sagittal midline, at the inferior limit of the tem-
poral lobes, and at the anterior and superior limits of
the cerebellum, to constrain the tractography algo-
rithm. To exclude voxels with low connectivity, which
may have resulted from image noise and therefore not
reﬂect the underlying structure, the resulting connectiv-
ity maps of the MCP and those of the SCP were thresh-
olded to include voxels with connectivity values of 200
and 100, respectively, on a scale from 0–20,000, as
thresholding has largely been used in brain studies.
31–33
The SCP was characterized by a lower connectivity
than the MCP, and therefore a lower threshold
(100) was used to obtain a plausible tract, as seen in
Figure 2.
From all voxels within the seed mask, the tractogra-
phy algorithm generated 5000 individual pathways
based on the probability distributions on principle
ﬁbre direction, with a curvature threshold of 0.2 (cor-
responding to a minimum angle of approximately
 80 ). Finally, the probability of a course within a
given voxel was represented by the sum of these
samples passing through it. For each tract, the trajec-
tory obtained was checked to ensure the location
was anatomically plausible (Figure 2); the orientation
of the principal eigenvector in the tract was also visu-
ally checked in all subjects to ensure that they were
consistent with the known anatomy and across sub-
jects.
34 In two patients with RRMS, the connectivity
of one of the reconstructed tracts was too low to sur-
vive thresholding, and these data were therefore
excluded from the statistical analysis. One of these
two patients showed a lesion in the pons and a lesion
in the cerebral peduncle on the side where tract connec-
tivity did not survive thresholding, despite showing an
MCP which appeared to be properly reconstructed;
therefore, we cannot exclude that these lesions
contributed to reduce the value of connectivity below
the chosen threshold. The average connectivity, mean
diﬀusivity (MD), fractional anisotropy (FA), axial dif-
fusivity (1) and radial diﬀusivity (average of 2 and
3) within the left and right MCP and SCP were
calculated.
Statistical analysis
All data were analysed using STATA version 9
(StataCorp, College Station, TX, USA, http://www
.stata.com). We found no statistically signiﬁcant diﬀer-
ences in tractography-derived measurements of both
cerebellar peduncles between the left and right sides,
and therefore measurements were averaged for each
peduncle, in each subject. Linear regression models
were used to compare cerebellar volumes and tracto-
graphy-derived measures of both the middle and supe-
rior cerebellar peduncles between subject groups, using
a group indicator, and controlling for age and gender
by including them as covariates. TIV was also entered
as a covariate when investigating diﬀerences in cerebel-
lar volumes in order to normalize for diﬀerences in
head size, whilst the number of voxels in the tract was
entered as a covariate when investigating diﬀerences in
tract-derived measures.
The relative contribution of MRI measures of WM
damage (DTI-derived measures and normalized
Figure 2. Example of the tractography reconstruction of the
middle cerebellar peduncle (a) and (b) and superior cerebellar
peduncle (c) and (d) overlaid on the fractional anisotrophy image
in coronal view (a) and (c) and axial view (b) and (d).
Figure 1. The seed masks of the middle cerebellar peduncle
(a)–(c) and superior cerebellar peduncle (d)–(f) overlaid onto the
MNI-152 T1-weighted brain image, in axial view (a) and (d),
coronal view (b) and (e), and sagittal view (c) and (f).
1082 Multiple Sclerosis Journal 17(9)cerebellar WM volume) and GM damage (normalized
cerebellar GM volume) to disability, as measured by
the 9-HPT and TWT, was investigated in the MS
patients using linear regression analysis, with the
inverse of the scores used (i.e. a more positive score
represented less disability), to make the scores normally
distributed. The association of age and gender with test
scores was determined in univariate analyses, and they
were entered into the regression analyses as covariates
if the association was signiﬁcant; the number of tract
voxels was also entered when investigating the contri-
bution of DTI-derived measures of both cerebellar
peduncles to test scores. Ordinal logistic regression
was used to assess the relative contributions of GM
and WM damage to C-FSS and EDSS score. To
assess whether tractography-derived values of the
MCP and SCP (MD, FA, axial and radial diﬀusivity)
were associated with normalized cerebellar GM volume
in the patient groups, linear regression was used to
model the data, with age, gender and number of
voxels added as covariates to control for the eﬀect of
these factors.
Results
Differences in cerebellar imaging measures
between groups
Mean normalized cerebellar GM and WM volumes and
tractography-derived measures in the MCP and SCP
are shown in Table 2. Two small lesions adjacent to
the 4th ventricle on the left side were seen in two
patients, and two bilateral lesions in the same location
were seen in another patient; however, in all these cases
the tractography-derived MCP and SCP appeared to be
correctly reconstructed.
Patients with PPMS showed a statistically signiﬁcant
decrease in MCP FA (mean diﬀerence  0.09 ( 10.7%)
95% Conﬁdence Intervals (CI)  0.15,  0.02, p¼0.012)
and a signiﬁcant increase in MCP radial diﬀusivity
(mean diﬀerence 0.726 10
 5 (7.7%), 95% CI
0.97 10
 5, 0.13 10
 3, p¼0.025) when compared
with controls, after correcting for age, gender, and
number of MCP voxels (Table 2). MCP FA was also
signiﬁcantly lower in patients with PPMS compared
with patients with RRMS (mean diﬀerence  0.08
(95% CI  0.15,  0.005, p¼0.037). There were no sta-
tistically signiﬁcant diﬀerences in any other diﬀusion
measures of the MCP or SCP, or in WM or GM cere-
bellar volumes between patients with PPMS and con-
trols. There were no signiﬁcant diﬀerences in any of the
MRI measures between patients with RRMS and
controls.
Contribution of cerebellar GM and WM injury
to disability
Cerebellar WM volume was associated with 9-HPT
score in patients with PPMS, independently of cerebel-
lar GM volume. For each 10mm
3 decrease in cerebellar
WM volume, the time taken to complete the 9-HPT
increased by 3.1s (95% CI 1.6, 40.8; p¼0.038). In the
same group of patients, the following correlations
between tractography-derived measures of the SCP
Table 2. Mean corrected values (adjusted for age, gender, total intracranial volume/number of tract voxels, as explained in the text)
and (SD) of cerebellar grey matter and white matter volumes and diffusion-tractography measures in the middle and superior
cerebellar peduncles in controls, patients with relapsing remitting multiple sclerosis (RRMS), and patients with primary progressive
multiple sclerosis (PPMS)
Controls (n¼16) RRMS (n¼12) PPMS (n¼11)
Cerebellar GM volume (cm
3) 97.5 (9.2) 97.2 (7.6) 93.3 (16.2)
Cerebellar WM volume (cm
3) 20.4 (1.7) 20.8 (3.2) 18.9 (3.4)
Middle cerebellar peduncle
Fractional anisotropy 0.88 (0.12) 0.86 (0.17) 0.79 (0.13)
Mean diffusivity (mm
2/s 10
 3) 1.20 (0.066) 1.23 (0.080) 1.24 (0.090)
Radial diffusivity (mm
2/s 10
 3) 0.89 (0.086) 0.93 (0.13) 0.97 (0.12)
Axial diffusivity (mm
2/s 10
 3) 1.82 (0.11) 1.84 (0.071) 1.79 (0.095)
Superior cerebellar peduncle
Fractional anisotropy 0.43 (0.03) 0.42 (0.04) 0.41 (0.05)
Mean diffusivity (mm
2/s 10
 3) 0.97 (0.14) 1.54 (0.11) 1.03 (0.10)
Radial diffusivity (mm
2/s 10
 3) 0.64 (0.12) 0.69 (0.09) 0.70 (0.09)
Axial diffusivity (mm
2/s 10
 3) 1.25 (0.19) 1.36 (0.15) 1.32 (0.15)
GM, grey matter; WM, white matter.
Anderson et al. 1083and clinical scores, including TWT and 9-HPT, were
found, when adjusting for age, gender and number of
voxels in the SCP: (i) FA was associated with the
inverse of TWT (beta  0.0012, 95% CI  0.002,
0.0001, p¼0.047); (ii) MD was associated with the
inverse of TWT (beta 0.40, 95% CI 0.035, 0.78,
p¼0.035); (iii) RD was associated with the inverse of
TWT (beta 0.5, 95% CI 0.12, 0.88, p¼0.016)
(Figure 3); (iv) FA was associated with the inverse of
9-HPT (beta  0.15, 95% CI  0.28,  0.011, p¼0.037)
(Figure 3). No other associations were observed
between the tractography-derived measures of the
MCP or SCP, or cerebellar GM volume, and perfor-
mance on the clinical tests. In particular, no association
was found between MRI measures of cerebellar damage
and C-FSS.
Association between tissue damage in the
cerebellar GM and WM
Correcting for age, gender and the number of tract
voxels, there was no signiﬁcant association of normal-
ized cerebellar GM volumes with tractography-derived
values of the MCP and SCP in patients with either
RRMS or PPMS.
Discussion
We have performed a comprehensive assessment of cer-
ebellar involvement in MS using diﬀusion tractography
and volumetric analysis, and investigated its impact on
disability. Our main ﬁndings were: (i) patients with
PPMS showed reduced FA, which was mainly driven
by increased radial diﬀusivity, in the MCP when
compared with healthy controls and patients with
RRMS; (ii) cerebellar WM volume was associated
with worse performance on the upper limb motor
task in patients with PPMS; (iii) in patients with
PPMS, there were signiﬁcant associations between
SCP FA and upper limb function, and between SCP
FA and MD and walking ability. This latter relation-
ship was mainly driven by SCP radial diﬀusivity. We
also explored the association between WM and GM
damage in the cerebellum, and found that the extent
of damage in the WM was independent from that in
the GM in both groups of patients. We will discuss
these ﬁndings in turn.
Our ﬁnding of reduced FA in the MCP in patients
with PPMS extends the results of previous studies,
which have reported a widespread decrease in FA
across the brain,
35,36 by showing that the main cerebel-
lar connections, which contribute to associative, limbic,
sensory and motor circuits, are aﬀected.
29 Therefore,
diﬀusion-based tractography is able to reﬂect underly-
ing pathological changes and may complement the
information obtained with voxel-based analyses.
16 In
addition, our analysis suggests that the detected
decrease in FA was due to an increase in radial diﬀu-
sivity which, despite reﬂecting the water diﬀusion per-
pendicular to the main direction of ﬁbres, and therefore
being a marker of demyelination in animal studies,
37 is
not considered to selectively measure demyelination in
patient studies.
38
Surprisingly, we did not detect signiﬁcant diﬀerences
in any MRI-derived measure between patients with
RRMS and controls. This could indicate that patholog-
ical changes in the cerebellar tracts in this group are
subtle and below the sensitivity of the technique, or
Figure 3. Correlation between diffusion parameters of the superior cerebellar peduncle (SCP) and motor scores, as assessed by the
inverse of TWT and 9-HPT, in patients with primary progressive multiple sclerosis. 9-HPT, Nine-Hole Peg Test; FA, fractional
anisotropy; SCP, superior cerebellar peduncle; TWT, Timed 25-foot Walk Test.
1084 Multiple Sclerosis Journal 17(9)that the relatively small sample size may have limited
the detection of group diﬀerences (as suggested by the
wide 95% CIs obtained), as previous studies have
shown both reductions in GM in patients with
RRMS (which correlated with reduced performance
on the 9-HPT) and decreases in FA in infratentorial
normal-appearing WM.
13,39 Alternatively, it could be
that, in this particular RRMS cohort, there were gen-
uinely no diﬀerences in cerebellar characteristics when
compared with controls, and that the involvement of
other motor-related pathways would therefore account
for the impaired motor disability scores. Focal inﬂam-
matory demyelination in WM appears to predominate
in people with RRMS, whilst more diﬀuse WM pathol-
ogy is evidenced in PPMS,
1 and our results in subjects
with RRMS may therefore reﬂect a lack of diﬀuse
changes within normal-appearing WM.
In patients with PPMS, we found that decreased cer-
ebellar WM volume was associated with reduced per-
formance on the 9-HPT independently of cerebellar
GM volume. However, since this group of patients
showed a lower cerebellar WM volume when compared
with controls which did not reach statistical signiﬁ-
cance, this result must be taken with caution and
needs to be conﬁrmed by further study. Although we
have previously shown an association of cerebellar WM
volume with performance on the 9-HPT in patients
with RRMS and secondary progressive MS, our earlier
study found that this was not independent of cerebellar
GM volume, which is in contrast to the current study.
13
Interestingly, the same association with 9-HPT was
seen when the diﬀusion parameters of the SCP were
used, in particular FA. This upper limb test requires
manual dexterity, and therefore it is likely that WM
injury leads to a slowing of motor function. In addition,
FA, MD and, above all, radial diﬀusivity of the SCP,
signiﬁcantly correlated with speed of walking, as mea-
sured by the TWT. This suggests that not only damage
to the whole cerebellar WM, but also that of the SCP,
play a role in determining disability. The C-FSS, which
is part of the EDSS, did not show any association with
imaging measures of the cerebellar peduncles, which
may be in agreement with the reports that interruption,
even surgical transection, of either spinocerebellar or
cerebro-ponto-cerebellar pathways causes little, or
only transient, cerebellar dysfunction.
30 On the other
hand, interruption of dentatothalamic and dentatoru-
bral tracts (which run in the SCP) may cause an inten-
tional tremor
30 that aﬀects the upper limb function
(which is well captured by the 9-HPT).
With regard to investigating the association between
GM and WM damage, we did not ﬁnd any signiﬁcant
relationship between MCP and SCP diﬀusion parame-
ters and cerebellar GM volume, suggesting that the
observed WM damage in the cerebellum is (at least in
part) independent from GM damage. This ﬁnding sup-
ports the hypothesis that the relationship between
injury in these two compartments may vary across
brain regions; for example, it may be correlated when
the motor pathway and the associated motor cortex are
taken into account,
16 but is independent when the cer-
ebellar peduncles and the associated cerebellar cortex
are considered, as seen in this study. However, our
results have to be taken cautiously and considered to
be preliminary, as in our investigation no statistically
signiﬁcant diﬀerences in WM and GM volumes were
observed in people with MS compared with controls.
A key question which will be addressed in further stud-
ies is whether cerebellar GM lesions are associated with
cerebellar WM damage, and whether imaging parame-
ters including diﬀusion, measured in the cerebellar and
hemispheric cortices, which receive the aﬀerent ﬁbres
passing through the cerebellar peduncles, are associated
with damage in these ﬁbres.
An important methodological consideration is that a
large number of statistical tests (about 95) were per-
formed without formal correction for statistical com-
parisons. However, since we tested the hypotheses that
imaging measures in the main cerebellar connections
diﬀer between patients and controls, and that cerebellar
WM and GM injury contributes to disability, this study
can be considered to be hypotheses-driven rather than
truly exploratory; for this type of study, the need for
multiple comparisons correction is less relevant.
40
Nevertheless, we realise that it is important for
future studies to conﬁrm the result reported here in
order to increase our conﬁdence that cerebellar
WM injury is important in determining disability in
patients with PPMS. In addition, from a methodolog-
ical point of view, recent advances in tractography
algorithms and analysis, the introduction of non-
linear registration techniques, and the increased use
of 3T clinical scanners, may allow one to use tracto-
graphy to test new hypotheses and provide novel
insights into the organization of the whole cortico–
ponto–cerebellar system and the eﬀects on it induced
by brain diseases.
41
In conclusion, these ﬁndings extend previous stud-
ies in PPMS by showing that reduced ﬁbre coher-
ence aﬀects the main cerebellar connections, which
mediate important brain functions, and that the
whole cerebellar WM volume, which potentially reﬂects
axonal loss, and the damage in the SCP ﬁbres, may
play a role in determining motor dysfunction, as
assessed by the upper limb function test and speed of
walking. In addition, in both groups of patients,
injury in the GM and WM appears to occur indepen-
dently in the cerebellum, suggesting that the association
between GM and WM pathology may vary with brain
region.
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